TScan Therapeutics, Inc (TCRX) IPO Opens 20% Lower

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. META
5. FFAI
6. FFR
7. FICO
8. CART
9. LLY
10. TSLA

Go back to TScan Therapeutics, Inc (TCRX) IPO Opens 20% Lower

TScan Therapeutics, Inc (TCRX) Price 6.7M Share IPO at $15/sh

July 16, 2021 5:00 AM EDT

TScan Therapeutics, Inc. (NASDAQ: TCRX), a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the pricing of its initial public offering of 6,666,667 shares of common stock at a public offering price of $15.00 per share, for gross proceeds of $100.0 million, before underwriting discounts, commissions, and offering expenses payable by TScan. In addition, TScan has granted the underwriters an option for a period of 30 days to purchase up to 1,000,000 additional shares of common stock... More